Alere, Inc. and its San Diego subsidiary, agreed to pay $38.75 million to resolve False Claims Act charges for billing the Medicare program for defective rapid point-of-care testing devices. Alere ...
Shares of Alere (NYSE: ALR), a provider of diagnostic tests to the medical community for disease detection, plunged as much as 16% during Friday's trading session after releasing disappointing ...
There's no foolproof way to know the future for Alere (NYS: ALR) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as ...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So what: Alere ...
Alere's Apollo technology, a fully integrated health management solution connecting providers, payers and patients, combined with Business Process Management (BPM) technology from Pegasystems, will ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere Inc at a lower price than it had ...
, an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced the launch of its Clinical Surveillance product for hospitals, which is an automated ...
Shares of Alere plunged Friday morning after the company disclosed in a filing that one of its units has seen its Medicare enrollment revoked. The Centers for Medicare & Medicaid Services alleged that ...
What: Shares of Alere (NYSE: ALR), a pioneer of quick, point-of-care diagnostics, sank by 22.9% in April, according to data from S&P Global Market Intelligence. All it took was an off-the-cuff comment ...
Federal criminal investigators have opened a new front in a probe of diagnostic testing company Alere, according to a new report that comes as the firm continues trying to sell itself to in a ...
North suburban-based Abbott Laboratories is making up with Alere after nearly a year of fighting, agreeing to buy the Massachusetts-based company for a lower price and ending its legal battles over ...
Alere Inc. was promised quick treatment by a Delaware judge set to hear its complaint that Abbott Laboratories is stalling to avoid going through a $5.8 billion purchase of the medical diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results